Establishment and characterization of a cholangiocarcinoma cell line (RMCCA-1) from a Thai patient

World Journal of Gastroenterology

Volumn 12, Issue 40, 2006, Pages 6500-6506

  Rattanasinganchan, Panthip ^a   Leelawat, Kawin ^a,b,c   Treepongkaruna, Sa Ard ^b   Tocharoentanaphol, Chintana ^c   Subwongcharoen, Somboon ^b   Suthiphongchai, Tuangporn ^a   Tohtong, Rutaiwan ^a  

^a Mahidol University ^*  (Thailand)

^b RAJAVITHI HOSPITAL   (Thailand)

^c CHULABHORN RESEARCH INSTITUTE   (Thailand)

Author keywords

Cell line; Cholangiocarcinoma; Establishment; Invasion; mFISH; Migration

Indexed keywords

ALPHA FETOPROTEIN; CA 19-9 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; CYTOKERATIN; CYTOKERATIN 19; CYTOKERATIN 7; TUMOR MARKER;

ADULT; ANEUPLOIDY; ARTICLE; BILE DUCT CARCINOMA; CANCER CELL CULTURE; CANCER INVASION; CANCER PATIENT; CASE REPORT; CELL GROWTH; CELL INVASION; CELL MIGRATION; CELL MOTILITY; CELL PROLIFERATION; CHROMOSOME ABERRATION; CHROMOSOME ANALYSIS; CHROMOSOME NUMBER; CULTURE MEDIUM; DRUG RESPONSE; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; IN VITRO STUDY; METASTASIS; MONOLAYER CULTURE; PATHOGENESIS; THAILAND;

EID: 33751010766     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v12.i40.6500     Document Type: Article

References (21)

1. Khan SA, Davidson BR, Goldin R, Pereira SP, Rosenberg WM, Taylor-Robinson SD, Thillainayagam AV, Thomas HC, Thursz MR, Wasan H. Guidelines for the diagnosis and treatment of cholangiocarcinoma: consensus document. Gut 2005; 51: vi1-vi9
2. Sirica AE. Cholangiocarcinoma: molecular targeting strategies for chemoprevention and therapy. Hepatology 2005; 41: 5-15
3. de Groen PC, Gores GJ, LaRusso NF, Gunderson LL, Nagorney DM. Biliary tract cancers. N Engl J Med 1999; 341: 1368-1378
4. Vatanasapt V, Sriamporn S, Vatanasapt P. Cancer control in Thailand. Jpn J Clin Oncol 2002; 32 Suppl: S82-91
5. Thongprasert S. The role of chemotherapy in cholangio-carcinoma. Ann Oncol 2005; 16 Suppl 2: ii93-ii96
6. Sripa B, Pairojkul C. Pathology of Cholangiocarcinoma. In Liver Cancer in Thailand. 2000: 84-88
7. Sirisinha S, Tengchaisri T, Boonpucknavig S, Prempracha N, Ratanarapee S, Pausawasdi A. Establishment and characterization of a cholangiocarcinoma cell line from a Thai patient with intrahepatic bile duct cancer. Asian Pac J Allergy Immunol 1991; 9: 153-157
8. Sripa B, Leungwattanawanit S, Nitta T, Wongkham C, Bhudhisawasdi V, Puapairoj A, Sripa C, Miwa M. Establishment and characterization of an opisthorchiasis-associated cholangiocarcinoma cell line (KKU-100). World J Gastroenterol 2005; 11: 3392-3397
9. MacDougall JR, Bani MR, Lin Y, Rak J, Kerbel RS. The 92-kDa gelatinase B is expressed by advanced stage melanoma cells: suppression by somatic cell hybridization with early stage melanoma cells. Cancer Res 1995; 55: 4174-4181
10. Frandsen TL. Assays for the study of human cancer cell invasion and metastasis. Fibrinolysis 1992; 6: 71-76
11. Quax PH, de Bart AC, Schalken JA, Verheijen JH. Plasminogen activator and matrix metalloproteinase production and extracellular matrix degradation by rat prostate cancer cells in vitro: correlation with metastatic behavior in vivo. Prostate 1997; 32: 196-204
12. Muangman S, Thippornwong M, Tohtong R. Anti-metastatic effects of curcusone B, a diterpene from Jatropha curcas. In Vivo 2005; 19: 265-268
13. Xu L, Han C, Wu T. A novel positive feedback loop between PPARdelta and PGE2 signaling pathways for human cholangiocarcinoma cell growth. J Biol Chem 2006; 11: 1-44
14. Ozkan H, Kaya M, Cengiz A. Comparison of tumor marker CA 242 with CA 19-9 and carcinoembryonic antigen (CEA) in pancreatic cancer. Hepatogastroenterology 2003; 50: 1669-1674
15. Watanabe M, Chigusa M, Takahashi H, Nakamura J, Tanaka H, Ohno T. High level of CA19-9, CA50, and CEA-producible human cholangiocarcinoma cell line changes in the secretion ratios in vitro or in vivo. In Vitro Cell Dev Biol Anim 2000; 36: 104-109
16. Taniguchi S, Iwamura T, Kitamura N, Yamanari H, Kojima A, Hidaka K, Seguchi K, Setoguchi T. Protein-free culture of the human pancreatic cancer cell line, SUIT-2. Hum Cell 1994; 7: 207-214
17. Adachi M, Sekine T, Umemoto A, Tsukikawa S, Imai K, Yachi A. Mechanism of clearance of circulating CA19-9 in rats. Tumour Biol 1990; 11: 51-58
18. Kim DG, Park SY, You KR, Lee GB, Kim H, Moon WS, Chun YH, Park SH. Establishment and characterization of chromosomal aberrations in human cholangiocarcinoma cell lines by cross-species color banding. Genes Chromosomes Cancer 2001; 30: 48-56
19. Storto PD, Saidman SL, Demetris AJ, Letessier E, Whiteside TL, Gollin SM. Chromosomal breakpoints in cholangiocarcinoma cell lines. Genes Chromosomes Cancer 1990; 2: 300-310
20. Shimizu Y, Demetris AJ, Gollin SM, Storto PD, Bedford HM, Altarac S, Iwatsuki S, Herberman RB, Whiteside TL. Two new human cholangiocarcinoma cell lines and their cytogenetics and responses to growth factors, hormones, cytokines or immunologic effector cells. Int J Cancer 1992; 52: 252-260
21. Gil-Benso R, Martinez-Lorente A, Pellin-Perez A, Navarro-Fos S, Gregori-Romero MA, Carda C, Callaghan R, Peydro-Olaya A, Llombart-Bosch A. Characterization of a new rat cell line established from 2′ AAF-induced combined hepatocellular cholangiocellular carcinoma. In Vitro Cell Dev Biol Anim 2001; 37: 17-25